Patents by Inventor Christopher Reiter

Christopher Reiter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of regulating angiogenesis through stabilization of PEDF
    Publication number: 20090149381
    Abstract: The invention provides methods of inhibiting angiogenesis within a tissue, promoting neuron protection within a tissue, and treating a disease in a mammal, wherein (a) a gene transfer vector encoding a protein of a serpin superfamily or a therapeutic fragment or variant thereof or (b) a protein of a serpin superfamily or a therapeutic fragment or variant thereof is administered with an inhibitor of matrix metalloprotease (MMP). Alternatively, the method comprises administration of (a) a protein of a serpin superfamily or therapeutic fragment or variant thereof or (b) a gene transfer vector encoding a protein of a serpin superfamily or a therapeutic fragment or variant thereof, wherein the protein or nucleic acid encoding the protein comprises at least one mutation which renders the protein of the serpin superfamily resistant to cleavage by an MMP.
    Type: Application
    Filed: October 10, 2008
    Publication date: June 11, 2009
    Applicant: GenVec, Inc.
    Inventors: Christopher Reiter, Miguel E. Carrion, Melissa M. Hamilton, Lisa Wei, C. Richter King
  • METHODS OF REGULATING ANGIOGENISIS THROUGH STABILIZATION OF PEDF
    Publication number: 20070232541
    Abstract: The invention provides methods of inhibiting angiogenesis within a tissue, promoting neuron protection within a tissue, and treating a disease in a mammal, wherein (a) a gene transfer vector encoding a protein of a serpin superfamily or a therapeutic fragment or variant thereof or (b) a protein of a serpin superfamily or a therapeutic fragment or variant thereof is administered with an inhibitor of matrix metalloprotease (MMP). Alternatively, the method comprises administration of (a) a protein of a serpin superfamily or therapeutic fragment or variant thereof or (b) a gene transfer vector encoding a protein of a serpin superfamily or a therapeutic fragment or variant thereof, wherein the protein or nucleic acid encoding the protein comprises at least one mutation which renders the protein of the serpin superfamily resistant to cleavage by an MMP.
    Type: Application
    Filed: May 18, 2007
    Publication date: October 4, 2007
    Applicant: GenVec, Inc.
    Inventors: Christopher Reiter, Miguel Carrion, Lisa Wei, Melissa Hamilton, C. King